vs
PRECISION BIOSCIENCES INC（DTIL）与KKR Real Estate Finance Trust Inc.（KREF）财务数据对比。点击上方公司名可切换其他公司
PRECISION BIOSCIENCES INC的季度营收约是KKR Real Estate Finance Trust Inc.的1.3倍（$34.2M vs $25.8M），PRECISION BIOSCIENCES INC净利率更高（58.9% vs -101.7%，领先160.6%），PRECISION BIOSCIENCES INC同比增速更快（5261.1% vs -26.6%），过去两年PRECISION BIOSCIENCES INC的营收复合增速更高（39.5% vs -18.8%）
精准生物科学公司是一家上市的美国临床阶段基因编辑企业，总部位于北卡罗来纳州达勒姆，成立于2006年。该公司依托自主研发的ARCUS基因组编辑平台，专注于开发体内和体外两类基因编辑疗法。
KKR房地产金融信托公司是全球投资机构KKR旗下的专业房地产金融平台，主要发起、收购并管理优先担保商业地产贷款组合，抵押物多为美国各地的优质机构级商业地产，通过贷款利息收入为投资者提供稳定的经风险调整后的回报。
DTIL vs KREF — 直观对比
营收规模更大
DTIL
是对方的1.3倍
$25.8M
营收增速更快
DTIL
高出5287.7%
-26.6%
净利率更高
DTIL
高出160.6%
-101.7%
两年增速更快
DTIL
近两年复合增速
-18.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $34.2M | $25.8M |
| 净利润 | $20.1M | $-26.2M |
| 毛利率 | — | — |
| 营业利润率 | 36.6% | -105.1% |
| 净利率 | 58.9% | -101.7% |
| 营收同比 | 5261.1% | -26.6% |
| 净利润同比 | 213.5% | -229.6% |
| 每股收益（稀释后） | $2.62 | $-0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DTILKREF
| Q4 25 | $34.2M | $25.8M | ||
| Q3 25 | $13.0K | $25.3M | ||
| Q2 25 | $18.0K | $30.2M | ||
| Q1 25 | $29.0K | $31.3M | ||
| Q4 24 | $638.0K | $35.1M | ||
| Q3 24 | $576.0K | $37.0M | ||
| Q2 24 | $49.9M | $40.4M | ||
| Q1 24 | $17.6M | $39.1M |
净利润DTILKREF
| Q4 25 | $20.1M | $-26.2M | ||
| Q3 25 | $-21.8M | $13.8M | ||
| Q2 25 | $-23.5M | $-29.7M | ||
| Q1 25 | $-20.6M | $-4.9M | ||
| Q4 24 | — | $20.3M | ||
| Q3 24 | $-16.4M | $-7.4M | ||
| Q2 24 | $32.7M | $25.8M | ||
| Q1 24 | $8.6M | $-3.1M |
营业利润率DTILKREF
| Q4 25 | 36.6% | -105.1% | ||
| Q3 25 | -158976.9% | 50.4% | ||
| Q2 25 | -121538.9% | -101.3% | ||
| Q1 25 | -76248.3% | -18.3% | ||
| Q4 24 | — | 55.8% | ||
| Q3 24 | -3693.6% | -19.6% | ||
| Q2 24 | 48.4% | 63.3% | ||
| Q1 24 | -23.8% | -8.7% |
净利率DTILKREF
| Q4 25 | 58.9% | -101.7% | ||
| Q3 25 | -167476.9% | 54.4% | ||
| Q2 25 | -130666.7% | -98.5% | ||
| Q1 25 | -70913.8% | -15.5% | ||
| Q4 24 | — | 57.7% | ||
| Q3 24 | -2851.6% | -20.0% | ||
| Q2 24 | 65.6% | 63.9% | ||
| Q1 24 | 48.8% | -7.9% |
每股收益（稀释后）DTILKREF
| Q4 25 | $2.62 | $-0.49 | ||
| Q3 25 | $-1.84 | $0.12 | ||
| Q2 25 | $-2.13 | $-0.53 | ||
| Q1 25 | $-2.21 | $-0.15 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | $-2.25 | $-0.19 | ||
| Q2 24 | $4.67 | $0.29 | ||
| Q1 24 | $1.70 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $115.6M | $84.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $92.2M | $1.2B |
| 总资产 | $154.4M | $6.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DTILKREF
| Q4 25 | $115.6M | $84.6M | ||
| Q3 25 | $44.9M | $204.1M | ||
| Q2 25 | $62.2M | $107.7M | ||
| Q1 25 | $77.2M | $106.4M | ||
| Q4 24 | $86.3M | $104.9M | ||
| Q3 24 | $101.2M | $108.8M | ||
| Q2 24 | $123.6M | $107.2M | ||
| Q1 24 | $137.8M | $106.5M |
股东权益DTILKREF
| Q4 25 | $92.2M | $1.2B | ||
| Q3 25 | $16.6M | $1.2B | ||
| Q2 25 | $34.1M | $1.2B | ||
| Q1 25 | $49.3M | $1.3B | ||
| Q4 24 | $56.4M | $1.3B | ||
| Q3 24 | $64.9M | $1.4B | ||
| Q2 24 | $74.7M | $1.4B | ||
| Q1 24 | $37.2M | $1.4B |
总资产DTILKREF
| Q4 25 | $154.4M | $6.5B | ||
| Q3 25 | $93.5M | $6.5B | ||
| Q2 25 | $108.9M | $6.8B | ||
| Q1 25 | $124.4M | $6.6B | ||
| Q4 24 | $136.4M | $6.4B | ||
| Q3 24 | $153.3M | $6.8B | ||
| Q2 24 | $165.8M | $7.1B | ||
| Q1 24 | $184.7M | $7.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-11.3M | $72.3M |
| 自由现金流经营现金流 - 资本支出 | $-11.3M | — |
| 自由现金流率自由现金流/营收 | -32.9% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | -0.56× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DTILKREF
| Q4 25 | $-11.3M | $72.3M | ||
| Q3 25 | $-15.3M | $18.5M | ||
| Q2 25 | $-20.3M | $21.1M | ||
| Q1 25 | $-19.1M | $15.9M | ||
| Q4 24 | $-58.4M | $132.6M | ||
| Q3 24 | $-5.9M | $49.1M | ||
| Q2 24 | $-14.9M | $30.6M | ||
| Q1 24 | $-19.0M | $34.5M |
自由现金流DTILKREF
| Q4 25 | $-11.3M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-20.3M | — | ||
| Q1 25 | $-19.1M | — | ||
| Q4 24 | $-58.7M | — | ||
| Q3 24 | $-6.0M | — | ||
| Q2 24 | $-14.9M | — | ||
| Q1 24 | $-19.1M | — |
自由现金流率DTILKREF
| Q4 25 | -32.9% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -112627.8% | — | ||
| Q1 25 | -65917.2% | — | ||
| Q4 24 | -9199.8% | — | ||
| Q3 24 | -1033.2% | — | ||
| Q2 24 | -29.9% | — | ||
| Q1 24 | -108.4% | — |
资本支出强度DTILKREF
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 11.1% | — | ||
| Q1 25 | 220.7% | — | ||
| Q4 24 | 39.2% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.5% | — |
现金转化率DTILKREF
| Q4 25 | -0.56× | — | ||
| Q3 25 | — | 1.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.54× | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.45× | 1.19× | ||
| Q1 24 | -2.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
